Where is FabRx located?

FabRx is headquartered in London, United Kingdom. It is registered at HENWOOD HOUSE,HENWOOD,ASHFORD,KENT,ENGLAND,TN24 8DH.

How many employees does FabRx have?

As of Aug 31, 2026, the latest employee count at FabRx is 12.

Where does FabRx rank among its competitors?

FabRx ranks 23rd amongst 85 active competitors, of which 14 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was CurifyLabs, which secured $14M in Jul, 2026.

Who are the top competitors of FabRx?

FabRx's top competitors include Aprecia Pharmaceuticals, Xlife sciences and CurifyLabs. Among them, CurifyLabs secured the most recent funding round in July, 2026.

FabRx - 2026 Company Profile, Team, Competitors & Financials

FabRx is an unfunded company based in London (United Kingdom), founded in 2014 by Simon Gaisford, Abdul Basit, Bill Lindsay and Alvaro Goyanes. It operates as a 3D printed drugs. FabRx has not raised any funding yet. The company has 85 active competitors, including 14 funded and 11 that have exited. Its top competitors include companies like Aprecia Pharmaceuticals, Xlife sciences and CurifyLabs.

Company Details

FabRx, University College London’s School of Pharmacy spin-off, has been researching and focusing on developing 3D printed medicines and drug-loaded medical devices. Printlets™ is the company's proprietary platform technology which formulates and manufactures 3D printed medicines with any drug compounds

Website: fabrx.co.uk
Social
Phone Number: +44 **********
Registered Address: HENWOOD HOUSE,HENWOOD,ASHFORD,KENT,ENGLAND,TN24 8DH

Key Metrics

Founded Year

2014

Location

London, United Kingdom

Stage

Unfunded

Ranked

23^rd among 85 active competitors

Employee Count

12 as on Aug 31, 2026

Similar Companies

Aprecia Pharmaceuticals & 98 more

View FabRx's full profile

FabRx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Fabrx Limited CIN: 9166556 , United Kingdom, Active	Aug 06, 2014	-	5 (As on Oct 31, 2024)

FabRx has not raised any funding rounds yet.

The founders of FabRx are Simon Gaisford, Abdul Basit, Bill Lindsay and Alvaro Goyanes.

Here are the details of FabRx's key team members:

Simon Gaisford: Co-Founder of FabRx.
Abdul Basit: Co-Founder of FabRx.
Bill Lindsay: Co-Founder of FabRx.
Contact Info: 1 email address
Alvaro Goyanes: Co-Founder of FabRx.
Contact Info: 1 email address

View details of FabRx's Founder profiles and Board Members

FabRx's employee count trend

FabRx has 12 employees as of Aug 26. Here is FabRx's employee count trend over the years:

Uncover FabRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of FabRx include Aprecia Pharmaceuticals, Xlife sciences and CurifyLabs. Here is the list of Top 10 competitors of FabRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aprecia Pharmaceuticals 2003, Langhorne (United States), Acquired	Develops & manufactures orodispersible formulations of highly prescribed high-dose medications using proprietary drug delivery systems.	$176M	Deerfield, Hercules Capital & 2 others	60/100
2nd	Xlife sciences 2013, Zurich (Switzerland), Public	Developer of drugs for multiple diseases	$62.8M	-	58/100
3rd	CurifyLabs 2021, Helsinki (Finland), Series A	Provider of digital 3D printing solutions for personalized medicine	$33.8M	Healthcap, Springvest & 8 others	57/100
4th	ROKIT Healthcare 2012, Seoul (South Korea), Public	Provider of 4D bio-printer solutions for tissue regenerative	$30M	DRADS Capital, Korean Development Bank & 16 others	54/100
5th	Allevi 2014, Philadelphia (United States), Acquired	3D bioprinting solutions: bioprinters, bioinks, and software for tissue engineering	$2.33M	500 Global, Ben Franklin Technology Partners ... & 14 others	47/100
6th	CTIBiotech 2009, Lyon (France), Funding Raised	Develops 3D human tissue models	-	Bpifrance, Government of France	46/100
7th	Cyfuse 2010, Bunkyo (Japan), Public	Developer of 3D tissue engineering technology	$16.6M	JAFCO Group, UTEC & 12 others	45/100
8th	BICO 2016, Boston (United States), Public	Provider of technologies, products, and services for life sciences research purposes	-	Fore C Investment, Europa & 1 others	45/100
9th	Inventia Life Science 2013, Alexandria (Australia), Unfunded	Manufacturer of drop on demand three dimensional cell bioprinting platforms	-	-	44/100
10th	CELLINK 2016, Boston (United States), Public	Developer of 3D bioprinters and bioinks for research purposes	-	Sahlgrenska Science Park, Europa & 1 others	43/100
23rd	FabRx 2014, London (United Kingdom), Unfunded	3D printed drugs	-	-	34/100